EGEivind Gottlieb-Vedi

Eivind Gottlieb-Vedi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Eivind Gottlieb-Vedi has a total of 41 co-authors. Here are the top co-authors by number of shared publications:

  • Fredrik Mattsson

    Upper Gastrointestinal Surgery, Department of Molecular medicine and Surgery, Karolinska Institutet, and Karolinska University Hospital, Stockholm, Sweden

    4 shared publications
  • Jesper Lagergren

    Department of Molecular Medicine and Surgery, Karolinska Institute, Stockholm, Sweden; School of Cancer and Pharmacological Sciences, King's College London, London, United Kingdom

    4 shared publications
  • Jesper Lagergren

    Upper Gastrointestinal Surgery, Department of Molecular Medicine and Surgery, Karolinska Institutet, and Karolinska University Hospital, Blombäcks väg 23, plan 4, Stockholm, 17177, Sweden

    3 shared publications
  • Björn Klinge

    Faculty of Odontology, Malmo University, Malmo, Sweden

    2 shared publications
  • Ellinor Lundberg

    Upper Gastrointestinal Surgery, Department of Molecular medicine and Surgery, Karolinska Institutet, and Karolinska University Hospital, Stockholm, Sweden

    2 shared publications
  • Ellinor Wiström

    Upper Gastrointestinal Surgery, Department of Molecular medicine and Surgery, Karolinska Institutet, and Karolinska University Hospital, Stockholm, Sweden

    2 shared publications

Latest Publications

  • Open Access

    Peritonsillar abscess as a clinical sign of oropharyngeal cancer – a Swedish national cohort study

    by Eivind Gottlieb-Vedi, Giola Santoni, Sanna Toppila-Salmi, Antti Mäkitie, Shao-Hua Xie, Jesper Lagergren

    Purpose: Patients older than 40 years with peritonsillar abscess may routinely undergo follow-up to detect oropharyngeal cancer, but this approach lacks scientific evidence. This study aimed to assess the hypothesis that oropharyngeal cancer is not overrepresented in patients with peritonsillar abscess. Methods: This population-based, nationwide Swedish cohort study compared all patients diagnosed with peritonsillar abscess during 2005–2023 with an age-, date-, and sex-matched non-exposed group from the same cohort. Conditional logistic regression provided odds ratios (OR) with 95% confidence intervals (CI) for oropharyngeal cancer within 1 year after peritonsillar abscess diagnosis, or matching date. Except for the three matching variables, the OR were adjusted for tobacco smoking, alcohol overconsumption, and comorbidity in a multivariable model. Results: Oropharyngeal cancer was diagnosed in 30 patients out of 64,244 occurrences of peritonsillar abscess (0.05%), compared to 9 out of 642,440 individuals in the comparison group (0.0014%). All 39 oropharyngeal cancers occurred in individuals aged 40 or older. Peritonsillar abscess was associated with an increased 1-year risk of oropharyngeal cancer (adjusted OR 3.51, 95% CI 2.75–4.26). In substrata of age, the strongest association was observed for patients aged 60 years and above (adjusted OR 4.54, 95% CI 3.07–6.02), corresponding to 2.8 cases per 1000 patients, while the age group 40–59 years had an OR of 2.76 (95% CI 1.80–3.72). Conclusion: Peritonsillar abscess may indicate an underlying oropharyngeal cancer only in rare cases. Given the low incidence of oropharyngeal cancer after peritonsillar abscess, routine follow-up is questionable or may be limited to older patients.

  • Open Access

    Length of the proximal resection margin and survival after surgery for oesophageal cancer

    by Ellinor Wiström, Fredrik Mattsson, Eivind Gottlieb-Vedi, Joonas H. Kauppila, Jesper Lagergren

  • ASO Visual Abstract: Dental health and survival following surgery for esophageal cancer

    by Kenzo Buchli, Eivind Gottlieb-Vedi, Fredrik Mattsson, Ellinor Wiström, Björn Klinge, Pernilla Lagergren, Jesper Lagergren

  • Open Access

    Dental Health and Survival Following Surgery for Esophageal Cancer

    by Kenzo Buchli, Eivind Gottlieb-Vedi, Fredrik Mattsson, Ellinor Wiström, Björn Klinge, Pernilla Lagergren, Jesper Lagergren

    Background: Most patients who undergo esophagectomy for esophageal cancer develop tumor recurrence and die within 5 years of surgery. An impact of preoperative dental status on survival in this patient group has been suggested but remains uncertain. Methods: This national Swedish cohort study included 871 patients who underwent esophagectomy for esophageal cancer (adenocarcinoma or squamous cell carcinoma) between 2011 and 2020 and were followed up until 2024. The exposure was the number of remaining teeth, based on dentist visits within 5 years before the esophagectomy, categorized into five (quintiles) and 10 (deciles) groups. The main outcome was all-cause 5-year mortality. Data were retrieved from medical records and national complete registries. Multivariable Cox regression provided hazard ratios (HRs) with 95% confidence intervals (CIs), adjusted for age, sex, comorbidity, tumor histology, neoadjuvant therapy, education level, and pathological tumor stage. Results: There were no statistically significant associations between the number of remaining teeth and the risk of all-cause 5-year mortality, independent of the categorization of the number of teeth. The HR was 1.13 (95% CI 0.85–1.51) comparing the lowest quintile of remaining teeth ( n = 0–19) with the highest quintile ( n = 29–32), and the HR was 0.98 (95% CI 0.64–1.52) comparing the lowest decile of remaining teeth ( n = 0–10) with the highest decile ( n = 31–32). There were no statistically significant associations in any of the subgroup analyses of age, comorbidity, or education. Conclusion: This study did not identify any association between the number of remaining teeth and the risk of 5 year mortality in patients who underwent esophagectomy for esophageal cancer.


  • Open Access

    Type of anastomosis and risk of anastomotic insufficiency after oesophagectomy: a bi-national population-based cohort study

    by Ellen Jonson, Eivind Gottlieb-Vedi, Fredrik Mattsson, Emilia Putila, Ville E.J. Sirviö, Olli Helminen, Mika Helmiö, Heikki Huhta, Anna Junttila, Raija Kallio, et al.


  • Open Access

    ASO Author Reflections: Advancements in Esophageal Cancer Surgery—A Swedish Perspective

    by Ellinor Jenny Gunilla Lundberg, Fredrik Mattsson, Eivind Gottlieb-Vedi, Jesper Lagergren

  • Open Access

    Prediction of conditional survival in esophageal cancer in a population-based cohort study

    by Shao-Hua Xie, Giola Santoni, Matteo Bottai, Eivind Gottlieb-Vedi, Pernilla Lagergren, Jesper Lagergren

    Background: The authors aimed to produce a prediction model for survival at any given date after surgery for esophageal cancer (conditional survival), which has not been done previously. Materials and Methods: Using joint density functions, the authors developed and validated a prediction model for all-cause and disease-specific mortality after surgery with esophagectomy, for esophageal cancer, conditional on postsurgery survival time. The model performance was assessed by the area under the receiver operating characteristic curve (AUC) and risk calibration, with internal cross-validation. The derivation cohort was a nationwide Swedish population-based cohort of 1027 patients treated in 1987–2010, with follow-up throughout 2016. This validation cohort was another Swedish population-based cohort of 558 patients treated in 2011–2013, with follow-up throughout 2018. Results: The model predictors were age, sex, education, tumor histology, chemo(radio)therapy, tumor stage, resection margin status, and reoperation. The medians of AUC after internal cross-validation in the derivation cohort were 0.74 (95% CI: 0.69–0.78) for 3-year all-cause mortality, 0.76 (95% CI: 0.72–0.79) for 5-year all-cause mortality, 0.74 (95% CI: 0.70–0.78) for 3-year disease-specific mortality, and 0.75 (95% CI: 0.72–0.79) for 5-year disease-specific mortality. The corresponding AUC values in the validation cohort ranged from 0.71 to 0.73. The model showed good agreement between observed and predicted risks. Complete results for conditional survival any given date between 1 and 5 years of surgery are available from an interactive web-tool: https://sites.google.com/view/pcsec/home. Conclusion: This novel prediction model provided accurate estimates of conditional survival any time after esophageal cancer surgery. The web-tool may help guide postoperative treatment and follow-up.